Prevention of rheumatic fever
Read Online
Share

Prevention of rheumatic fever report of a WHO Expert Committee. by WHO Expert Committee on the Prevention of Rheumatic Fever Expert Committee on the Prevention of Rheumatic Fever.

  • 252 Want to read
  • ·
  • 80 Currently reading

Published by World Health Organization in Geneva .
Written in English

Subjects:

  • Rheumatic fever -- Prevention.,
  • Rheumatic fever -- prevention & control.

Book details:

Edition Notes

Includes bibliographical references.

SeriesWorld Health Organization technical report series -- no. 342, Technical report series (World Health Organization) -- 342.
Classifications
LC ClassificationsRA8 .A25 no. 342
The Physical Object
Pagination27 p.
Number of Pages27
ID Numbers
Open LibraryOL22387581M
LC Control Number79003203

Download Prevention of rheumatic fever

PDF EPUB FB2 MOBI RTF

Rheumatic Fever is an inflammatory disease that occurs following a Streptococcus pyogenes infection, such as streptococcal pharyngitis or scarlet fever. Believed to be caused by antibody cross-reactivity that can involve the heart, joints, skin, and brain,[ 1 ] the illness typically develops two to three weeks after a streptococcal infection. prevention of rheumatic fever/rheumatic heart disease in sixteen developing Joint WHO/ISFC meeting on rheumatic fever/rheumatic heart disease control with emphasis on primary prevention, Geneva, 7–9 September Geneva, World Health Organization, (WHO/CVD ). 6. The WHO global programme for the prevention of RF/RHD. Report of a. Rheumatic fever (RF) is an inflammatory disease that can involve the heart, joints, skin, and brain. The disease typically develops two to four weeks after a streptococcal throat infection. Signs and symptoms include fever, multiple painful joints, involuntary muscle movements, and occasionally a characteristic non-itchy rash known as erythema kauainenehcp.com: Autoimmune disease triggered . Rheumatic Fever. Recommend on Facebook Tweet Share Compartir. National Notifiable Time Periods. National notifiable time periods for condition; National Notifiable Centers for Disease Control and Prevention Office of Public Health Scientific Services (OPHSS) Center for Surveillance, Epidemiology, and Laboratory Services (CSELS).

The first edition of this book was an excellent instrument to assist in the control of this disease. The present volume with dissemination of knowledge to health personnel will contribute to closing the gap between knowledge and implementation and it links with WHO's endeavors in prevention and control of rheumatic fever and rheumatic heart Cited by: 3. Note: Citations are based on reference standards. However, formatting rules can vary widely between applications and fields of interest or study. The specific requirements or preferences of your reviewing publisher, classroom teacher, institution or organization should be applied. Feb 28,  · Acute Rheumatic Fever and Rheumatic Heart Disease is a concise, yet comprehensive, clinical resource highlighting must-know information on rheumatic heart disease and acute rheumatic fever from a global perspective. Covering the major issues dominating the field, this practical resource presents sufficient detail for a deep and thorough understanding of the latest treatment options, Pages: The feasibility of and justification for rheumatic fever control programmes in developing countries has been often questioned. A co-operative study co-ordinated by the World Health Organization has now demonstrated that systematic prevention of rheumatic fever recurrences not only benefits the patients concerned but also has economic advantages.

Dec 01,  · Primary prevention is the treatment of acute streptococcal pharyngitis in order to prevent the initial attack of rheumatic fever. In general, once the diagnosis has been made, antibiotic therapy is indicated. In some countries where the incidence of streptococcal pharyngitis and rheumatic fever is especially high, a national decision may be taken to treat all children presenting with acute. Mar 01,  · Very concise review of epidemiology of streptococcal infections, diagnostic criteria (including republication of the Modified Jones Criteria, from Circulation , ), programs for treatment of streptococcal infections, and prophylaxis for rheumatic fever subjects; statement of research needs requiring particular attention. The United States of America was represented in the WHO Expert. Jan 16,  · Rheumatic Fever is an immune mediated inflammatory disease caused by group A Streptococcus or Streptococcus kauainenehcp.com is one of the important public health problems in developing countries. Rheumatic fever frequently occurs in young children and adolescents of age years. Rheumatic fever (RF) and rheumatic heart disease (RHD) are still major medical and public health problems mainly in developing countries. Pilot studies conducted during the last five decades in developed and developing countries indicated that the prevention and control of RF/RHD is kauainenehcp.com by: